Journey Medical Corporati... (DERM)
NASDAQ: DERM
· Real-Time Price · USD
7.92
-0.14 (-1.74%)
At close: Jun 02, 2025, 2:26 PM
-1.74% (1D)
| Bid | 7.87 |
| Market Cap | 184.56M |
| Revenue (ttm) | 56.24M |
| Net Income (ttm) | -8.3M |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -21.41 |
| Forward PE | 9.17 |
| Analyst | Buy |
| Ask | 7.98 |
| Volume | 88,773 |
| Avg. Volume (20D) | 93,552.3 |
| Open | 8.17 |
| Previous Close | 8.06 |
| Day's Range | 7.91 - 8.13 |
| 52-Week Range | 3.54 - 8.25 |
| Beta | 0.87 |
About DERM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DERM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DERM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+18.93%
Journey Medical shares are trading higher after th...
Unlock content with
Pro Subscription
9 months ago
+14.22%
Journey Medical shares are trading higher after the company reported better-than-expected Q2 revenue results.
2 weeks ago · seekingalpha.com
Journey Medical Corporation (DERM) Q1 2025 Earnings Call TranscriptJourney Medical Corporation (NASDAQ:DERM ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founde...
2 months ago · seekingalpha.com
Journey Medical Corporation (DERM) Q4 2024 Earnings Call TranscriptJourney Medical Corporation (NASDAQ:DERM ) Q4 2024 Results Conference Call March 26, 2025 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Found...
